Overview
Mizuha Hashiguchi practices in Yokohama, Japan. Hashiguchi is rated as an Experienced expert by MediFind in the treatment of Long Haul COVID. Their top areas of expertise are Lung Adenocarcinoma, Chronic Obstructive Pulmonary Disease (COPD), COVID-19, and Long Haul COVID.
Their clinical research consists of co-authoring 13 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Long Haul COVID.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Hashiguchi isExperienced. Learn about COVID-19.
- Long Haul COVIDHashiguchi isExperienced. Learn about Long Haul COVID.
- Lung AdenocarcinomaHashiguchi isExperienced. Learn about Lung Adenocarcinoma.